Caxton Corporation’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,456
Closed -$300K 17
2017
Q2
$300K Buy
+12,456
New +$300K 0.47% 9
2017
Q1
Sell
-21,923
Closed -$338K 12
2016
Q4
$338K Buy
21,923
+3,014
+16% +$46.5K 1.15% 7
2016
Q3
$246K Hold
18,909
1.1% 6
2016
Q2
$263K Buy
+18,909
New +$263K 0.3% 8